Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers.
Jong Hoon HyunYongjung ParkYoung Goo SongSang-Hoon HanSoon Young ParkSin Hye KimJi Su ParkSo Young JeonHye Sun LeeKyoung-Hwa LeePublished in: Yonsei medical journal (2022)
The frequency of adverse events occurring after the first dose of the ChAdOx1 was significantly reduced after the second dose. Interestingly, the elevation of anti-SARS-CoV-2 S titer was significantly increased in the group with pain after the first dose.